.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Cantor Fitzgerald
Johnson and Johnson
Merck
Farmers Insurance
Fuji
AstraZeneca
Chubb
Deloitte
UBS

Generated: September 26, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Which drugs does patent 7,291,324 protect, and when does it expire?


Patent ► Subscribe protects HALFLYTELY and is included in one NDA. There have been zero Paragraph IV challenges on Halflytely and Halflytely

Summary for Patent: ► Subscribe

Title:Method of bowel cleansing
Abstract:Stimulant laxative in combination with an osmotic laxative produces safe and effective bowel and colon cleansing with a reduced volume of liquid input. Administering to a patient an oral stimulant laxative, such as bisacodyl, followed, after a biologically determined interval, by a reduced volume of a PEG in water solution cleanses the bowels and colon in preparation for diagnostic colonoscopy, without the profuse uncontrollable diarrhea that typically follows either ingestion of large volume isotonic ravages, or smaller volume hypertonic lavages.
Inventor(s): Dennett, Jr.; Edmund V. (Walpole, MA), Raleigh, Jr.; Robert M. (Braintree, MA), Cleveland; Mark V B. (Duxbury, MA), Pelham; Russell W. (Duxbury, MA)
Assignee: Braintree Laboratories Inc. (Braintree, MA)
Application Number:10/277,620
Patent Claim Types:
see list of patent claims
Use; Formulation;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Braintree
HALFLYTELY
bisacodyl; polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride
FOR SOLUTION, TABLET, DELAYED RELEASE;ORAL021551-003Jul 16, 2010DISCNYesNo► Subscribe► Subscribe GASTROINTESTINAL LAVAGE INDICATED FOR CLEANSING OF THE COLON AS A PREPARATION FOR COLONOSCOPY IN ADULTS
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Cantor Fitzgerald
Mallinckrodt
UBS
Novartis
Express Scripts
Daiichi Sankyo
Farmers Insurance
Covington
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot